10/19/09 | Yissum Introduces Novel Nanotechnology for Revolutionizing Imaging Using T-rays |
This invention will make T-ray based cameras and spectrometers practical, ushering a new era in security and medical imaging. | |
10/19/09 | France Biotech Unveils Its Proposals for the French State's National Loan |
Life science must become one of France's strategic development axes | |
10/14/09 | Pfizer Receives Clearance From The U.S. Federal Trade Commission And The Canadian Competition Bureau For Wyeth Acquisition |
Pfizer expects to close the transaction on October 15, 2009 | |
10/14/09 | Bio-Matrix Scientific Group, Inc. to Aggressively Pursue Private and Public Grants to Fund Research for Development of Stem Cell Treatment of Chronic Obstructive Pulmonary Disease (COPD) |
Initiates Activities by Retaining Grant Development Firm to Source Research Funding | |
10/13/09 | Southwall to Supply Heat Mirror® Insulating Glass for New Line of Owens Corning High Performance Fiberglass Windows |
Energy-Saving Glass Using Heat Mirror Suspended Film Technology to Be Produced by Southwall Joint Venture | |
10/13/09 | Urovalve Receives Additional Funding from NIH to Advance Its Surinate® Urinary Catheter |
Urovalve, Inc. is a privately held company located in the Enterprise Development Center at New Jersey Institute of Technology (NJIT). | |
10/13/09 | SanDisk Ships World’s First Flash Memory Cards with 64 Gigabit X4 (4-Bits-Per-Cell) NAND Flash Technology |
Tel Aviv University had provided a significant contribution to the X4 advanced error correcting and digital signal processing technology, which was licensed exclusively to SanDisk by Ramot at Tel Aviv University Ltd., TAU’s technology transfer company. | |
10/08/09 | University of Florida Formalizes Commitment to Locate Research Facility in Orlando |
Lake Nona Medical City Location Facilitates Collaboration with Burnham Institute | |
10/06/09 | Lamborghini Leads Development of Carbon Fiber with Investment in Aerospace Research and Design Center |
~ Automobili Lamborghini Advanced Composite Structures Laboratory Opens with Public Unveiling at University of Washington ~ | |
10/06/09 | Tetraphase Pharmaceuticals Completes Series B Financing to Support the Advancement of Novel Antibiotic Drug Candidates |
- Raises $10M to close first tranche of $25M Financing - Tetraphase Pharmaceuticals was established in August 2006 to advance and commercialize the ground-breaking synthetic chemistry platform developed by internationally recognized chemist, Dr. Andrew Myers of Harvard University. | |
[ <- 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 -> ] |